Seoul, South Korea

Ki Chul Hwang

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Yonsei University. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ki Chul Hwang. Retrieved from https://idiyas.com/inventor/ki-chul-hwang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ki Chul Hwang: Innovator in Stem Cell Research

Introduction

Ki Chul Hwang is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of stem cell research, particularly in the differentiation of mesenchymal stem cells. His innovative work has the potential to impact the treatment of various cartilage diseases.

Latest Patents

Ki Chul Hwang holds a patent for the "Use of compounds for inducing differentiation of mesenchymal stem cells to chondrocytes." This patent describes a compound of Formula 1 that effectively induces the differentiation of mesenchymal stem cells into chondrocytes. The pharmaceutical composition developed from this compound can be utilized in treating cartilage diseases, including arthritis and cartilage defects. The specific induction of differentiation by the compound of Formula 1 highlights its therapeutic potential.

Career Highlights

Throughout his career, Ki Chul Hwang has been associated with esteemed institutions such as Yonsei University and Catholic Kwandong University Industry Foundation. His work in these organizations has allowed him to advance his research and contribute to the scientific community.

Collaborations

Ki Chul Hwang has collaborated with notable colleagues, including Yang Soo Jang and Gyoon Hee Han. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation.

Conclusion

Ki Chul Hwang's contributions to stem cell research and his innovative patent demonstrate his commitment to advancing medical science. His work holds promise for the effective treatment of cartilage diseases, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…